Morepen Laboratories Complete Financial Statements
In FY2026, Morepen Laboratories (MOREPENLAB) reported revenue ₹493 Cr, net profit ₹16 Cr and EPS ₹0.28, with a net profit margin of 3.2% and ROE of 1.3%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review MOREPENLAB earnings multiple to evaluate earnings-based valuation against sector peers.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
MOREPENLAB Revenue, Net Profit & EBITDA — Year-on-Year Growth
MOREPENLAB YoY (Mar 2025 vs Mar 2026) — revenue +4.7%, net profit -20.0%, EBITDA -29.8%, expenses +8.5%. Explore MOREPENLAB fundamental worth to estimate fundamental worth using multiple valuation models.
MOREPENLAB Income Statement — Revenue, EBITDA & Net Profit
Morepen Laboratories revenue ₹493 Cr, EBITDA ₹33 Cr, net profit ₹16 Cr, EPS ₹0.28 (2026) — net profit margin 3.2%. For live price, earnings ratios and company overview, see MOREPENLAB stock price BSE.
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Jun 2018 | Dec 2018 | Sept 2017 | Jun 2017 | Dec 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 493 | 442 | 471 | 430 | 488 | 443 | 427 | 459 | 458 | 425 | 367 | 404 | 449 | 404 | 372 | 303 | 350 | 398 | 291 | 388 | 399 | 340 | 208 | 259 | 310 | 216 | 220 | 203 | 235 | 174 | 172 | 164 | 215 | 151 | 132 | 156 |
| Expenses | 460 | 381 | 424 | 401 | 438 | 394 | 375 | 404 | 417 | 388 | 348 | 375 | 394 | 374 | 350 | 288 | 328 | 353 | 256 | 343 | 364 | 305 | 188 | 231 | 278 | 198 | 197 | 184 | 215 | 157 | 154 | 152 | 195 | 130 | 121 | 137 |
| EBITDA | 33 | 61 | 47 | 29 | 50 | 49 | 53 | 55 | 42 | 37 | 19 | 29 | 55 | 30 | 22 | 16 | 22 | 45 | 35 | 45 | 35 | 36 | 21 | 28 | 33 | 18 | 23 | 20 | 20 | 17 | 18 | 12 | 19 | 20 | 11 | 19 |
| Operating Profit Margin % | 5.00% | 7.00% | 9.00% | 6.00% | 10.00% | 10.00% | 11.00% | 11.00% | 8.00% | 8.00% | 4.00% | 7.00% | 11.00% | 7.00% | 5.00% | 5.00% | 6.00% | 11.00% | 11.00% | 11.00% | 8.00% | 9.00% | 9.00% | 10.00% | 10.00% | 7.00% | 10.00% | 10.00% | 7.00% | 10.00% | 10.00% | 7.00% | 8.00% | 13.00% | 7.00% | 12.00% |
| Depreciation | 6 | 11 | 17 | 9 | 10 | 2 | 10 | 6 | 5 | 8 | 7 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 9 | 8 | 8 | 8 | 11 | 12 | 9 | 10 | 10 | 9 | 10 | 8 | 9 | 8 |
| Interest | 4 | 4 | 5 | 4 | 4 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 2 | 1 | 1 | 0 | 1 | -9 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 |
| Profit Before Tax | 23 | 46 | 26 | 16 | 35 | 46 | 42 | 48 | 35 | 29 | 11 | 21 | 44 | 22 | 14 | 8 | 14 | 47 | 28 | 39 | 27 | 28 | 11 | 20 | 24 | 9 | 11 | 8 | 11 | 7 | 7 | 3 | 9 | 11 | 1 | 10 |
| Tax | 8 | 5 | 5 | 4 | 8 | 11 | 14 | 12 | 9 | 7 | 3 | 6 | 12 | 7 | 2 | 3 | 5 | 10 | 1 | 8 | 6 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 16 | 41 | 20 | 11 | 28 | 35 | 29 | 36 | 27 | 21 | 8 | 15 | 32 | 16 | 12 | 6 | 9 | 37 | 27 | 31 | 22 | 27 | 11 | 19 | 24 | 4 | 11 | 8 | 11 | 7 | 7 | 3 | 9 | 11 | 1 | 10 |
| Earnings Per Share (₹) | 0.28 | 0.75 | 0.35 | 0.20 | 0.50 | 0.65 | 0.54 | 0.71 | 0.49 | 0.42 | 0.16 | 0.29 | 0.63 | 0.33 | 0.27 | 0.12 | 0.15 | 0.83 | 0.59 | 0.68 | 0.48 | 0.60 | 0.25 | 0.43 | 0.53 | 0.09 | 0.23 | 0.17 | 0.24 | 0.16 | 0.15 | 0.05 | 0.20 | 0.25 | 0.03 | 0.23 |
MOREPENLAB Balance Sheet — Assets, Liabilities & Shareholders' Equity
MOREPENLAB total assets ₹1,778 Cr, total equity ₹1,187 Cr, total liabilities ₹ Cr (2025) — ROE 1.3%.
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 1,778 | 1,293 | 1,111 | 1,070 | 858 | 664 | 615 | 586 | 538 | 524 | 489 |
| Current Assets | 1,159 | 889 | 756 | 734 | 527 | 372 | 300 | 243 | 192 | 157 | 115 |
| Fixed Assets | 489 | 307 | 267 | 252 | 225 | 216 | 236 | 264 | 272 | 297 | 323 |
| Capital Work in Progress | 28 | 25 | 17 | 14 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 85 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1,176 | 960 | 827 | 804 | 631 | 446 | 379 | 321 | 267 | 227 | 167 |
| LIABILITIES | |||||||||||
| Total Liabilities | |||||||||||
| Current Liabilities | 91 | 44 | 37 | 36 | 30 | 28 | 23 | 20 | 18 | 58 | 74 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 1,187 | 847 | 752 | 578 | 424 | 284 | 253 | 226 | 196 | 300 | 287 |
| Share Capital | 110 | 102 | 102 | 96 | 90 | 90 | 90 | 90 | 90 | 210 | 210 |
| Reserves & Surplus | 1,047 | 745 | 651 | 457 | 291 | 194 | 163 | 136 | 106 | 91 | 78 |
MOREPENLAB Cash Flow Statement — Operating, Investing & Financing
Morepen Laboratories operating cash flow ₹32 Cr, investing ₹-322 Cr, financing ₹300 Cr, net cash flow ₹10 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 32 | 73 | -91 | -60 | 51 | 11 | 17 | 63 | 41 | 50 | 51 |
| Investing Activities | -322 | -83 | -47 | -32 | -70 | -13 | -13 | -27 | -14 | -27 | -32 |
| Financing Activities | 300 | 5 | 144 | 66 | 47 | 6 | 0 | -38 | -24 | -27 | -19 |
| Net Cash Flow | 10 | -5 | 6 | -26 | 28 | 4 | 4 | -1 | 3 | -5 | 0 |